In contrast, other studies using alternative sample sources and methods of analysis found AURKA SLR increased in cancer samples, specifically in breast and lung cancers, where such increase even correlated with poor prognosis and survival [24, 50, 52]. The gene discussed is AURKA; the disease is lung carcinoma.